(Q41138730)

English

The aminoglycosides

scientific article published on November 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

The aminoglycosides (English)

1 reference

Europe PubMed Central

27 September 2017

author name string

R S Edson

1

1 reference

Europe PubMed Central

27 September 2017

C L Terrell

2

1 reference

Europe PubMed Central

27 September 2017

language of work or name

0 references

publication date

1 November 1991

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

66

1 reference

Europe PubMed Central

27 September 2017

11

1 reference

Europe PubMed Central

27 September 2017

1158-1164

1 reference

Europe PubMed Central

27 September 2017

Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Deafness Complicating Antibiotic Therapy of Hepatic Encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Pharmacology of Gentamicin in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Pharmacokinetics of Gentamicin in Children and Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Serum Protein Binding of the Aminoglycoside Antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

The pharmacokinetics of amikacin and gentamicin in volunteers: a comparison of individual differences

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Factors affecting aminoglycoside disposition: effects of circadian rhythm and dietary protein intake on gentamicin pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Tobramycin and gentamicin concentrations in the serum of normal and anephric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Pharmacokinetics of amikacin in patients with impaired renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Autoradiographic Localization of [ 3 H]Gentamicin in the Proximal Renal Tubules of Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Penetration of Parenterally Administered Gentamicin into the Cerebrospinal Fluid in Experimental Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Cerebrospinal fluid penetration of amikacin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Gentamicin Levels in the Human Biliary Tract

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Gentamicin inactivation in purulent exudates: role of cell lysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Letter: Prolonged excretion of gentamicin in a patient with umimpaired renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Five-year surveillance of aminoglycoside usage in a university hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Three-year experience with amikacin sulfate as an exclusive surgical aminoglycoside in a large acute-care hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Successful treatment of a pancreatic Nocardia asteroides abscess with amikacin and surgical drainage

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Antimicrobial susceptibility patterns of Nocardia asteroides

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

General mechanisms of resistance to antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Prevalence and mechanisms of aminoglycoside resistance. A ten-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Resistance to Six Aminoglycosidic Aminocyclitol Antibiotics Among Enterococci: Prevalence, Evolution, and Relationship to Synergism with Penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Experimental studies on nephrotoxicity of aminoglycosides at low doses. Mechanisms and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

What is the cost of nephrotoxicity associated with aminoglycosides?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Once-daily aminoglycoside administration: new strategies for an old drug

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965798-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0025-6196(12)65798-X

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41138730&oldid=2094155724"